🇺🇸 FDA
Pipeline program

Hemay005 tablet

HM005CO1S01

Phase 1 small_molecule completed

Quick answer

Hemay005 tablet for Chronic Obstructive Pulmonary Disease is a Phase 1 program (small_molecule) at Anhui Hemay Pharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Anhui Hemay Pharmaceutical Co., Ltd
Indication
Chronic Obstructive Pulmonary Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials